BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8486426)

  • 1. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
    Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
    Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against endometrial carcinoma by combination-product oral contraceptives.
    Hulka BS; Chambless LE; Kaufman DG; Fowler WC; Greenberg BG
    JAMA; 1982 Jan 22-29; 247(4):475-7. PubMed ID: 7033575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
    Colditz GA
    Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and neoplasia of the uterine corpus.
    Schlesselman JJ
    Contraception; 1991 Jun; 43(6):557-79. PubMed ID: 1868733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception and the big "C".
    Chandran R
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
    Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for ovarian cancer: a case-control study.
    Booth M; Beral V; Smith P
    Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.